February in review: GLP-1 nutrition strategies, probiotic innovations, and food reformulation
February’s highlights include accelerating innovations around GLP-1s, advancing gut microbiome research, growing scrutiny of infant formula safety, and ongoing debates over supplement quality, protein policies, and food reformulation. In our February review, Nutrition Insight features some of the month’s biggest stories, including how supplements can help bridge nutrition gaps related to GLP-1 use and rapid weight loss. In the UK, researchers identified gut microbes that could unlock next-generation probiotics, and we examined Novonesis’ biosolutions toolbox for healthier foods.This Technical Paper is brought to you by Bioiberica.
Kerry representatives Mathieu Millette, Ph.D., and Haelim Choi discuss the clinical relevance of BC30 (Bacillus coagulans GBI-30, 6086), showing benefits for Caucasian and Chinese populations in gastrointestinal comfort. Millette, who is scientific director at Bio-K+ and Choi, senior global marketing manager for Digestive Health, also address regulatory challenges in product differentiation, as health claims must remain general despite solid clinical trials. New probiotics face stricter hurdles and delays — showing scientific innovations are outpacing regulatory approval timelines and limiting expansion potential.
Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position
Latest headlines

Mood-enhancing ingredients Mar 2026

Omega-3 supplement market trendsMar 2026
Multimedia
Kerry representatives Mathieu Millette, Ph.D., and Haelim Choi discuss the clinical relevance of BC30 (Bacillus coagulans GBI-30, 6086), showing benefits for Caucasian and Chinese populations in gastrointestinal comfort. Millette, who is scientific director at Bio-K+ and Choi, senior...
































